Press Release

CD BIOPARTICLES ANNOUNCES EXPANDED OFFERINGS OF POLYDIMETHYLSILOXANE FOR CUTTING-EDGE RESEARCH



CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

FOR IMMEDIATE RELEASE

23/01/2024

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced an expanded portfolio of Polydimethylsiloxane (PDMS) products, empowering researchers with versatile and biocompatible tools for groundbreaking discoveries.

Polydimethylsiloxane is an elastomeric polymer with interesting properties for biomedical applications, including non-physiological reactivity, excellent resistance to biodegradation, biocompatibility, chemical stability, gas permeability, good mechanical properties, excellent optical transparency, and easy replication molding. Based on these properties, PDMS has been used in a wide range of applications such as micropumps, catheter surfaces, dressings and bandages, microvalves, optical systems, in vitro disease studies, implants, microfluidics, and photonics.

In addition, PDMS is the most widely used material for the manufacture of microfluidic devices, which are an important technology for the development of systems for drug delivery, DNA sequencing, clinical diagnostics, point-of-care testing, and chemical synthesis. The materials used in these systems should be biocompatible, optically transparent, rapid to prototype and low cost to manufacture, characteristics of PDMS.

In the pharmaceutical field, PDMS derivatives have been widely used as coatings for controlled drug delivery systems. The main advantages of these materials are the ease of tuning the desired drug release pattern, improved film formation and storage stability. Recognizing its immense potential, CD Bioparticles has significantly broadened its PDMS offerings to cater to the evolving needs of researchers, including PDMS Grafted Triethoxysilane, Si-PSSNa, Butyl-PDMS-Triethoxysilane, and Cyclocarbonate-PDMS-Cyclocarbonate.

CD Bioparticles offers various Biopolymers & Synthetic Polymers for customers worldwide. CD Bioparticles is committed to easing the burden on its customers by reducing cumbersome chemical synthesis, formulation and purification, improving drug loading efficiency and yield of drug delivery materials, and helping customers track and image the distribution of polymer-based (nano)materials to avoid strong immunoreactivity or xenobiotic reactions to the materials.

CD Bioparticles can provide customers with a wide range of functional groups/targeting ligands/tags covering polymers for loading, modification, specific targeting, tracking and detection, as well as functional groups in different densities or different chemical geometries to fabricate biomaterials with controllable functionality and other physical/chemical properties (e.g. mechanical properties of cross-linking agents), helping customers to improve the biocompatibility, activity and functionality of polymers that allow for controlled delivery profiles of drug delivery vehicles.

Beyond the diverse product range, CD Bioparticles also provides exceptional customer support, offering expert guidance and technical assistance to researchers navigating the intricacies of PDMS utilization.

With its expanded PDMS portfolio and unwavering commitment to scientific advancement, CD Bioparticles strives to provide its customers with the most accurate and reliable tools for drug delivery. For more information on the new PDMS, please visit https://www.cd-bioparticles.net/polydimethylsiloxane.

About CD Bioparticles

CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.

Tags:
Polydimethylsiloxane  |  CD Bioparticles  |  

---

Organisation Profile:
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.






Press release contact details for CD Bioparticles

NameCD Bioparticles
Tel1-631-346-0027
Fax
Email
Websitehttps://www.cd-bioparticles.net/
OrganisationCD Bioparticles
Address
Town
County0
Postcode




Other press releases from CD Bioparticles

CD Bioparticles Launches Gene Silencing for Bio-research Application
CD Bioparticles Launches Gel Permeation Chromatography Resins
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis
CD Bioparticles Launches 3D Transfection Reagents for Bio-research Applications
CD Bioparticles Launches Affinity Chromatography Resins for Laboratory Usage
CD Bioparticles Announces Carrageenans for Scientific Applications
CD Bioparticles Launches New Chromatography Resins for Improved Analysis and Preparation of Chiral Compounds
CD Bioparticles Launches New Alginic Acids for Research Applications
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
CD Bioparticles Launches New Line of Bioinks for 3D Bioprinting
CD Bioparticles Launches New Quantum Dots Labeling & Conjugation Kits
CD Bioparticles Introduces New Extraction and Purification Kits for Rapid and Reliable DNA Isolation
CD Bioparticles Launches New Tissue Engineering Scaffolds for Researchers
CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD Bioparticles Announces the Launch of New Flow Cytometry Particles
CD Bioparticles Introduces the Launch of Engineered Tissue Scaffolds
CD Bioparticles Announces Polyamino Acids for Drug Delivery Applications
CD Bioparticles Launches New Line of Functional Polystyrene Particles
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles Unveils Versatile Plain Polystyrene Particles for Diverse Bioresearch Applications
CD Bioparticles Launches New Range of Low PDI Polymers for Drug Delivery Applications
CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis
CD Bioparticles Introduces Innovative Agarose Particles for Purification of Proteins and Antibodies
CD Bioparticles Announces New Line of Polyacrylamides for Drug Delivery Studies
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications
CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.